CHURCHILL MANAGEMENT Corp Sells 393 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

CHURCHILL MANAGEMENT Corp lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,180 shares of the medical equipment provider’s stock after selling 393 shares during the quarter. CHURCHILL MANAGEMENT Corp’s holdings in Intuitive Surgical were worth $1,668,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of ISRG. Baystate Wealth Management LLC boosted its holdings in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the last quarter. MCF Advisors LLC boosted its holdings in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the last quarter. Headinvest LLC purchased a new position in Intuitive Surgical during the 3rd quarter worth $28,000. Able Wealth Management LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $28,000. Finally, Stone House Investment Management LLC boosted its holdings in Intuitive Surgical by 100.0% during the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $432.56 on Friday. The firm has a market cap of $153.43 billion, a P/E ratio of 78.08, a P/E/G ratio of 5.59 and a beta of 1.39. The stock has a 50 day simple moving average of $397.13 and a two-hundred day simple moving average of $378.68. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $437.20.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. Intuitive Surgical’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.00 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent analyst reports. Robert W. Baird lowered their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. StockNews.com cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. BTIG Research lifted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Jefferies Financial Group lifted their target price on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research note on Friday, April 19th. Finally, Piper Sandler boosted their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $403.67.

Insider Activity

In other news, EVP Myriam Curet sold 5,318 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the sale, the executive vice president now owns 298 shares of the company’s stock, valued at $110,456.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, EVP Myriam Curet sold 5,318 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the sale, the executive vice president now owns 298 shares of the company’s stock, valued at $110,456.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 2,496 shares of the stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $402.89, for a total value of $1,005,613.44. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,956 shares of company stock valued at $6,927,011. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.